Register for email alerts and news feeds:
This journal | BMJ Group
rss
Drug and Therapeutics Bulletin 2005;43:25-28; doi:10.1136/dtb.2005.43425
Copyright © 2005 by the BMJ Publishing Group Ltd.

Simvastatin over the counter

Relevant BNF section: 2.12

In July 2004, simvastatin 10mg was reclassified in the UK from a Prescription-only medicine (PoM) to a Pharmacy (P) medicine and launched as Zocor Heart-Pro (Johnson & Johnson.MSD Consumer Pharmaceuticals). It is the first statin in the world to be sold without prescription. Zocor Heart-Pro is licensed to reduce the risk of a first major coronary heart disease (CHD) event in people likely to be at "moderate risk" of such problems. Here we review the rationale and process for reclassifying simvastatin 10mg as an over-the-counter product.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Reynolds, T. M., Mardani, A., Twomey, P. J., Wierzbicki, A. S. (2008). Targeted versus global approaches to the management of hypercholesterolaemia. The Journal of the Royal Society for the Promotion of Health 128: 248-254 [Abstract]  
  • Gotto, A. M. Jr (2006). Over-The-Counter Statins Are Worth Considering in Primary Prevention of Cardiovascular Disease. Circulation 114: 1310-1314 [Full Text]  
  • Mcelduff, P, Jaefarnezhad, M, Durrington, P N (2006). American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively. Heart 92: 1213-1218 [Abstract] [Full Text]  
  • Sleight, P., Pouleur, H., Zannad, F. (2006). Benefits, challenges, and registerability of the polypill. Eur Heart J 27: 1651-1656 [Abstract] [Full Text]